Riskpilot← Back to searchSign inGet full accessC. Ekstrand konsult AB
ABActiveOrg 5594439480Skohornsbacken 71Veterinary activities · NACE 7500Est. 20230 employees
Revenue 2025
SEK 137K
-29% vs 2024
EBITDA margin
81.6%
-28% vs 2024
Equity ratio
—
Financial strength
Net profit 2025
SEK 90K
-28% vs 2024
| Revenue | SEK 137K | -29% |
| EBITDA | SEK 112K | -28% |
| Net profit | SEK 90K | -28% |
| Total assets | SEK 183K | -13% |
| Equity | SEK 0 | -100% |
| Employees | 0 | — |
Legal name
C. Ekstrand konsult AB
Org number
5594439480
Legal form
Aktiebolag
NACE code
7500 · Veterinary activities
Founded
8 augusti 2023
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Företaget kommer bedriva konstultverksamhet inom farmakologi, med inriktning på veterinärmedicin. Det inkluderar sakkunnig/expertuppdrag, föreläsningar, rådgivning och forskningskonsultationer till både företag, organisationer och myndigheter. Försäljning kan ske till kunder i både Sverige och utomlands.
Address
Skohornsbacken 71
Email
calle.ekstrand@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 13 | 194 | 137 |
| Staff expenses | — | — | −8 |
| EBITDA | 6 | 156 | 112 |
| Depreciation & amort. | −0 | −0 | −0 |
| EBIT | 6 | 156 | 112 |
| Net financials | — | 1 | 1 |
| Profit before tax | 6 | 157 | 113 |
| Tax | −1 | −32 | 23 |
| Net profit | 5 | 125 | 90 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 33 | 211 | 183 |
| Equity | 30 | 155 | 0 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 3 | 56 | 28 |
| Total debt | 3 | 56 | 62 |
EBITDA margin
81.6%
This company
15.8%
Market median
+416% vs market
20232025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20232025
Return on equity
8970600.0%
This company
18.4%
Market median
+48753161% vs market
20232025
Net profit margin
65.5%
This company
8.1%
Market median
+709% vs market
20232025
Asset turnover
0.75×
This company
1.12×
Market median
-33% vs market
20232025
Debt / equity
182717.00×
This company
0.62×
Market median
-29470384% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Deputy Board Member | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of C. Ekstrand konsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Evert Ekstrand | Board of Directors | 0 companies |
| Karin Ingrid Ekstrand | Deputy Board Member | 0 companies |